Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Wall Street applies for triple-leveraged ETF to test regulators' risk tolerance

Wall Street applies for triple-leveraged ETF to test regulators' risk tolerance

金色财经金色财经2025/10/06 22:58
Show original

Jinse Finance reported that three asset management companies are planning to launch exchange-traded funds (ETFs) that amplify the price volatility of Tesla, bitcoin, and other assets to rare levels, once again testing regulators' tolerance for ultra-high-risk financial products. Defiance ETFs, Themes, and Direxion have submitted applications for leveraged products designed to deliver triple the daily returns of some of the market's most popular trading assets. This move is quite innovative: due to the volatility rules set by the U.S. Securities and Exchange Commission (SEC), which limit the level of leverage funds can offer, there are currently no triple-leveraged single-stock ETFs in the U.S. market.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.

Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.

智通财经•2026/09/29 03:11

Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request

A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.

智通财经•2026/09/29 02:46

After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.

Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.

智通财经•2026/09/29 02:46